HIV-2 and SIV vector systems

Somatic Cell and Molecular Genetics

Volumn 26, Issue 1-6, 2001, Pages 83-98

  Gilbert, James R ^a   Wong Staal, Flossie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL DIVISION; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LENTIVIRUS; PRIMATES; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035525979     PISSN: 07407750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021026730034     Document Type: Review

References (64)

1. Roe T, Reynolds TC, Yu G, Brown PO et al. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12:2099-2108.
2. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7:980-990.
3. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10:4239-4242.
4. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68:510-516.
5. Bukrinsky MI, Haggerty S, Dempsey MP et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365:666-669.
6. Gallay P, Swingler S, Aiken C et al. HIV-1 infection of non-dividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 1995; 80:379-388.
7. Gallay P, Swingler S, Song J et al. HIV-1 nuclear import is governed by phospho-tyrosine mediated binding of matrix to the core domain of integrase. Cell 1995; 83:569-576
8. Heinzinger NK, Bukinsky MI, Haggerty SA et al. The vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in non-dividing cells. Proc Natl Acad Sci USA 1994; 91:7311-7315.
9. Fletcher TM, Brichacek B, Sharova N et al. Nuclear import and cell cycle arrest functions of the HIV-1 vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J 1996; 15:6155-6165.
10. Buchschacher GL, Panganiban AT. Human immunodeficiency viruses for expression of foreign genes. J Virol 1992; 66:2731-2739.
11. Parolin C, Dorfman T, Palu G et al. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J Virol 1994; 68:3888-3895.
12. Carroll R, Lin JT, Dacquel EJ et al. A human immunodeficiency virus type 1 (HIV-1) based retroviral vector system utilizing stable HIV-1 packaging cell lines. J Virol 1994; 68:6047-6051.
13. Naldini L, Blomer U, Gallay P et al. In vivo delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272:263-267.
14. Chen Z, Telfer P, Gettie A et al. Genetic characterization of new west African simian immunodeficiency virus SIVsm: Geographic clustering of household-derived SIV strains with human immunodeficiency type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J Virol 1996; 70:3617-3627.
15. Desrosiers RC, Daniel MD, Li Y. HIV related lentiviruses of nonhuman primates. AIDS Res Human Retroviruses 1989; 5:465-473.
16. Peeters M, Koumare B, Mulanga C et al. Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali. AIDS Res Human Retroviruses 1998; 14:51-58.
17. Chen Z, Luckay A, Sodora D, Telfer P et al. HIV-2 seroprevalence and characterization of a new HIV-2 genetic subtype (F) within the natural range of SIV infected sooty mangabeys. J Virol 1996; 71:3953-3960.
18. Gardner, MB, Endres M, Barry P. Simian retroviruses: SIV and SRV. In: Levy J, ed. The Retroviridae. New York: Plenum Press, 1994:133-276.
19. Fauci AS, Desrosiers RC. Pathogenesis of HIV and SIV. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. New York: Cold Spring Harbor Laboratory Press, 1997:587-631.
20. Gayle HD, Gnaore E, Adjorlolo G et al. HIV-1 and HIV-2 infection in children in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr 1992; 5:513-7.
21. Dalgleish AG, Beverly PCL, Chapham PR et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312:763-767.
22. Sattentau QJ, Chapham PR, Weiss RA et al. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 1988; 2:1-9.
23. Alkhatib G, Broder CC, Combadiere C et al. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage tropic HIV-1. Science 1996; 272:1955-1958.
24. Feng Y, Broder CC, Kennedy PE et al. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-877.
25. Chen Z, Zhou P, Ho D et al. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997; 71:2705-2715.
26. Connor RI, Sheridan KE, Ceradini D et al. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997; 185:621-628.
27. McKnight A, Dittmar MT, Moniz-Periera J et al. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency type 2 as coreceptors with CD4. J Vir 1998; 72:4065-4071.
28. Guillon C, Van Der Ende ME, Boers PHM et al. Coreceptor usage of human immunodeficiency type 2 primary isolates and biological clones is broad and does not correlate with their syncitium-inducing capacities. J Vir 1998; 72:6260-6263.
29. Deng H, Unutmaz D, Kewelramani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997; 388:296-300.
30. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-126.
31. Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency type 1 infection. Nature 1995; 373:117-122.
32. Marlink R, Kanki P, Thior I et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-1590.
33. Kanki PJ, Travers KU, Mboup S et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943-946.
34. Pepin J, Morgan G, Dunn D et al. HIV-2-induced immunosuppression among asymptomatic West African prostitutes: Evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 1991; 5:1165-1172.
35. Barnett SW, Murthy KK, Herndier BG et al. An AIDS-like condition induced in baboons by HIV-2. Science 1994; 266:642-646.
36. Otren RA, Brown BG, Simon M et al. Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina. AIDS 1994; 8:297-306.
37. Looney DJ, McClure J, Kent SJ et al. A minimally replicative HIV-2 live-virus vaccine protects M nemestrina from disease after HIV-2287 challenge. Virology 1998; 242:150-160.
38. Castro BA, Nepomuccno M, Lerche NW, et al. Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. Virology 1991; 184:219-226.
39. Mamounas M, Looney DJ, Talbott R et al. An infectious chimeric human immunodeficiency virus type 2 (HIV-2) expressing the HIV-1 principal neutralizing determinant. J Virol 1995; 69:6424-6429.
40. Pavlakis GN. The molecular biology of human immunodeficiency virus type 1. In: DeVita JVT, Hellman S, Rosenberg SA, eds. AIDS: Biology, Diagnosis, Treatment and Prevention. 4th Ed. Philadelphia: Lippincott-Raven, 1996.
41. Arya SK. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): Functional domains and the search for trans-dominant negative mutants. AIDS Research and Human Retroviruses 1993; 9:839-848.
42. Emerman M, Guyader M, Montangier L et al. The specificity of the human immunodeficiency virus type 2 trans-activator is different from that of human immunodeficiency type 1. EMBO J 1987; 6:3755-3760.
43. Luciw P. Human immunodeficiency viruses and their replication. In: Fields BN, ed. Virology. New York: Raven Press, 1995:1881-1952.
44. Lewis N, Williams J, Rekosh D et al. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types 1 and 2 rex proteins. J Virol 1990; 64:1690-1697.
45. Jacque JM, Fernandez B, Arenzana-Seisdedos F, Thomas, D et al. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-B is needed for persistent viral replication in monocytes. J Virol 1996; 70:2930-2938.
46. Alcami J, Lain de Lera T, Folgueira L et al. Absolute dependence onB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 1995; 14:1552-15560.
47. Baeuerle PA, Kenkel T. Function and activation of NF-kappa B in the immune system. Ann Rev Immunol 1994; 12:141-179.
48. Thanos D, Maniaris T. NF-kappa B: A lesson in family values. Cell 1995; 80:529-532.
49. Linial ML, Miller AD. Retroviral RNA packaging: Sequence requirements and implications. In: Swanstrom R, Vogt PK, eds. Retroviruses-Strategies of Replication. Berlin: Springer Verlag, 1990:125-152.
50. Berkowitz RD, Hammarskjold ML, Helga-Maria C. 5' regions of HIV-1 are not sufficient for encapsidation: Implications for the HIV-1 packaging signal. Virology 1995; 212:718-723.
51. McBride MS, Panganiban AT. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J Virol 1996; 70:2963-2973.
52. Garzino-Demo A, Gallo RC, Arya SK. Human immunodeficiency virus type 2 (HIV-2): Packaging signal and associated negative regulatory element. Hum Gene Ther 1995; 6:177-184.
53. Arya SK, Zamani M, Kundra P. Human immunodeficiency type 2 lentivirus vectors for gene transfer: Expression and potential for helper virus-free packaging. Hum Gene Ther 1998; 9:1371-1380.
54. Poeschla E, Gilbert J, Li X et al. Identification of a human immunodeficiency type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J Virol 1998; 72:6527-6536.
55. McCann EM, Lever AM. Location of cis-acting sequences important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J Virol 1997; 71:4133-4137.
56. Rizvi TA, Panganiban AT. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency type 1 particles. J Virol 1993; 67:2681-2688.
57. Schnell T, Foley P, Wirth M et al. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther 2000; 11:439-447.
58. Kafri T, Blomer U, Peterson DA et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17:314-317.
59. White SM, Renda M, Nam N et al. Lentivirus vectors using human and simian immunodeficiency virus elements. J Vir 1999; 73:2832-2840.
60. Tang H, Gaietta GM, Fischer WH et al. A cellular cofactor for the constitutive transport element of type D retrovirus. Science 1997; 276:1412-1415.
61. Mautino MR, Ramsey WJ, Reiser J et al. Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant rev. Hum Gen Ther 2000; 11:895-908.
62. Mautino M, Keiser N, Morgan RA. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element. Gene Ther 2000; 7:1421-1424.
63. Miyoshi H, Blomer U, Takahashi M et al. Development of a self-inactivating lentiviral vector. J Vir 1998; 72:8150-8157.
64. Miyoshi H, Takahashi M, Gage FH et al. Stable and efficient gene transfer into the retina using and HIV-based lentiviral vector. PNAS, USA 1997; 94:10319-10323.